Hinke Siebinga

11PUBLICATIONS
20CO-AUTHORS
PharmacogenomicsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Forensic evaluation, inference and statisticsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 23, 2026
Semi-Physiological Population Pharmacokinetic Modeling of Oral and Intravenous Paracetamol to Quantify Presystemic Metabolism and Enterohepatic Recirculation.

Cedric Lau, Charlotte van Kesteren, Robert M Smeenk

|Nov 20, 2025
Reducing the Burden of Interaction Studies in Cancer Patients Using a Stable Isotopically Labeled Microtracer: A Proof-of-Concept Study with Alectinib.

Ma Ida Mohmaed Ali, Lisa T van der Heijden, Matthijs Tibben

|Apr 24, 2024
Quantification of biochemical PSA dynamics after radioligand therapy with [177Lu]Lu-PSMA-I&T using a population pharmacokinetic/pharmacodynamic model.

Hinke Siebinga, Berlinda J de Wit-van der Veen, Daphne M V de Vries-Huizing

|Oct 16, 2023
The cycle effect quantified: reduced tumour uptake in subsequent cycles of [177Lu]Lu-HA-DOTATATE during peptide receptor radionuclide therapy.

H Siebinga, J J M A Hendrikx, D M V de Vries-Huizing

|Aug 24, 2023
Predicting [177Lu]Lu-HA-DOTATATE kidney and tumor accumulation based on [68Ga]Ga-HA-DOTATATE diagnostic imaging using semi-physiological population pharmacokinetic modeling.

Hinke Siebinga, Berlinda J de Wit-van der Veen, Jos H Beijnen

|Jun 15, 2023
Predicting the effect of different folate doses on [68Ga]Ga-PSMA-11 organ and tumor uptake using physiologically based pharmacokinetic modeling.

Hinke Siebinga, Jeroen J M A Hendrikx, Alwin D R Huitema

Pageof 2

Frequent Collaborators

2 joint publications

Else A Aalbersberg

2 joint publications

Alwin D R Huitema

2 joint publications

Marcel P M Stokkel

2 joint publications

Linda de Wit-van der Veen